WordNet

(medicine) the act of caring for someone (as by medication or remedial training etc.); "the quarterback is undergoing treatment for a knee injury"; "he tried every treatment the doctors suggested"; "heat therapy gave the best relief"

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Amelioration of experimental autoimmune myasthenia gravis rats by blood purification treatment using 4-mercaptoethylpyridine-based adsorbent.

Ren J, Bai Y, Hao L, Dong Y, Pi Z, Jia L.SourceSchool of Life Science and Biotechnology, Dalian University of Technology, 2 Linggong Road, Dalian 116023, People's Republic of China.
Journal of biomedical materials research. Part A.J Biomed Mater Res A.2011 Sep 15;98(4):589-95. doi: 10.1002/jbm.a.33139. Epub 2011 Jun 30.
The role of immunoadsorption therapy is well established in the management of myasthenia gravis (MG), an autoimmune disorder characterized by muscle weakness and caused by circulating IgG antibodies with specificity against the acetylcholine receptor. Conventional immunoadsorbents that employ recomb
PMID 21721115

Tan IL, McArthur JC, Clifford DB, Major EO, Nath A.SourceFrom the Department of Neurology (I.L.T., J.C.M., A.N.), Johns Hopkins School of Medicine, Baltimore, MD; Department of Neurology (D.B.C.), Washington University, St Louis, MO; and Laboratory of Molecular Medicine and Neuroscience (E.O.M.), NINDS, NIH, Bethesda, MD.
Neurology.Neurology.2011 Aug 10. [Epub ahead of print]
OBJECTIVE: To study the outcome of patients with multiple sclerosis (MS) and with natalizumab-associated progressive multifocal leukoencephalopathy (PML) and immune reconstitution inflammatory syndrome (IRIS).METHODS: MedWatch reports from Biogen-Idec (manufacturer of natalizumab, TysabriR) were re
PMID 21832229

緒方浩顕,和田幸寛,溝渕正英,衣笠えり子,秋澤忠男
日本アフェレシス学会雑誌 29(2), 203-208, 2010-05-31
… In fact, immunoadsorption therapy has beneficial effects on cardiac function in patients with DCM. …
NAID 110007619226

清元秀泰,森脇久美子,西岡聡,東山智香子,原大雅
日本アフェレシス学会雑誌 29(2), 194-202, 2010-05-31
… This has led to a possible new therapy, immunoadsorption (IA), which removes antibodies in order to induce early hemodynamic improvement in patients with DCM. … However, the therapy of IA has not been accepted yet in Japan. … In conclusion, DFPP may be an effective and useful therapy for patients undergoing HD with severe heart failure due to DCM. …
NAID 110007619225